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Summary 
 
Remote monitoring for heart failure has been evaluated in numerous systematic 
reviews. The aim of this meta-review was to appraise their quality and synthesise 
results. We electronically searched online databases, performed a forward citation 
search and hand-searched bibliographies. Systematic reviews of remote monitoring 
interventions that were used for surveillance of heart failure patients were included. 
Seven (41%) systematic reviews pooled results for meta-analysis. Eight (47%) 
considered all non-invasive remote monitoring strategies. Five (29%) focused on 
telemonitoring. Four (24%) included both non-invasive and invasive technologies. 
According to AMSTAR criteria, ten (58%) systematic reviews were of poor 
methodological quality. In high quality reviews, the relative risk of mortality in patients 
who received remote monitoring ranged from 0.53 (95% CI=0.29-0.96) to 0.88 (95% 
CI=0.76-1.01). High quality reviews also reported that remote monitoring reduced the 
relative risk of all-cause (0.52; 95% CI=0.28-0.96 to 0.96; 95% CI=0.90–1.03) and 
heart failure-related hospitalizations (0.72; 95% CI=0.64–0.81 to RR 0.79; 95% 
CI=0.67-0.94) and, as a consequence, healthcare costs. As the high quality reviews 
reported that remote monitoring reduced hospitalizations, mortality and healthcare 
costs, research efforts should now be directed towards optimising these 
interventions in preparation for more widespread implementation. 
 
Keywords: Heart failure, remote monitoring, systematic review 
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INTRODUCTION 
 
The healthcare literature contains hundreds of thousands of interventional studies 
and is growing.1 Systematic reviews are performed to critically appraise and 
synthesise data from individual studies that focus on a specific clinical problem or 
question. In a systematic review, the methods used to identify, select and critically 
appraise relevant research and to collect and analyse data from the individual 
studies identified are explicitly stated.2 Moreover, to increase power, data collected 
from the individual studies included in a systematic review can be accumulated using 
statistical procedures in what is known as a ‘meta-analysis’.2 Clinical practice 
guidelines try to use the best available evidence to provide recommendations. As 
such, meta-analysis is accorded the highest level of evidence. However, in areas 
that have attracted a large amount of research, it is now common for there to be 
numerous systematic reviews and meta-analyses published.3, 4 Therefore, there is 
also a need for critical appraisal and synthesis of systematic reviews and meta-
analyses in order to ensure policy and practice decision-making is informed by the 
best available accumulated evidence. The ‘meta-review’, which is also known as an 
‘overview of systematic reviews’, can be used specifically for this purpose.2 The aim 
of a meta-review is to critically appraise and synthesise findings from systematic 
reviews and meta-analyses. This contrasts with a systematic review, in which the 
intent is to critically appraise and synthesise findings from individual studies. 
The methodological difference between a traditional systematic review, which may or 
may not also incorporate meta-analysis, and a meta-review, is that a meta-review 
only considers results reported in systematic reviews and meta-analyses, not results 
from individual studies. However, meta-reviews should utilise methods that are 
similar to a traditional systematic review. For example, in a meta-review, the 
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methods used to review the literature, conduct quality assessment of included 
reviews and synthesise findings, need to be explicitly stated.2 
Early identification of clinical deterioration in patients with heart failure by remotely 
monitoring for signs and symptoms of fluid accumulation or objectively measuring 
fluid status could help prevent hospitalization for acute decompensated heart 
failure.5 Remote monitoring interventions for heart failure are broadly categorized as 
either invasive or non-invasive. Invasive interventions involve direct measurement of 
physiological variables, such as heart rate and changes in pulmonary artery 
pressures, by an implanted device which is then transmitted for the health care 
provider to access. Non-invasive remote monitoring for heart failure can be further 
categorized as either telemonitoring or structured telephone support. Telemonitoring 
involves the transmission of physiological data, such as body weight, blood pressure 
and pulse oximetry, and other data, such as self-care practices, for the health care 
provider to access.6 Structured telephone support involves direct contact using 
simple telephone technology between a health care provider and the heart failure 
patient.6 Both invasive and non-invasive remote monitoring interventions for heart 
failure have been evaluated in a large body of research including numerous 
randomized controlled trials (RCTs), systematic reviews and meta-analyses. As 
such, in order to ensure policy and practice decision-making is informed by the best 
available accumulated evidence, there is a need for critical appraisal and synthesis 
of the systematic reviews and meta-analyses. 
For this reason, we conducted a meta-review of the systematic reviews and meta-
analyses that focused on remote monitoring in heart failure. The aim was to appraise 
and synthesise the systematic reviews that have assessed the effectiveness of 
remote monitoring for heart failure in order to aid policy and practice decision-making 
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regarding implementation of these interventions into clinical practice. 
METHODS 
We applied the principles of the Cochrane methodology to the meta-review.2 Our 
meta-review included a comprehensive literature search. The relevant reviews 
identified were then analysed by summarising and comparing the population, 
intervention, comparison and outcomes that were reported in each review. In 
addition, a quality appraisal of each review was undertaken using a validated tool.7  
Information sources and search strategy 
The following databases were searched: CINAHL; Cochrane Database of Systematic 
Reviews; JBI library of systematic reviews; EMBASE; Health source 
nursing/academic edition; and MEDLINE. The database searches were 
supplemented by manual searching of reference lists and a forward citation search 
was performed using Google Scholar. Only published reviews were considered. 
Independent reviewers (AC & MH-B) undertook investigation of all data sources to 
maximize the scope of the search, and to reduce errors and bias. Publication limits 
of between 1996 and 2012 (inclusive) were set for all literature searches. Only 
articles written in full-text English were included. All potentially relevant publications 
were retrieved in full-text for review purposes. The search used boolean operators to 
combine free text terms and/or MeSH terms including heart failure, cardiac failure, 
telehealth, telephone, telemonitoring, impedance cardiography, remote sensing 
technology and disease-management. A full list of the search terms used is 
presented in the Appendix. 
 
Study selection 
 
Titles and abstracts were initially screened (AC and MH-B) to eliminate articles that 
were clearly irrelevant. Potentially eligible publications were retrieved and the full text 
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version was reviewed in detail. Two reviewers (AC and MH-B) independently 
selected studies for inclusion and a third independent reviewer (RC) was available 
for arbitration. Inclusion and exclusion criteria for this meta-review are outlined in 
Box 1. 
Data extraction 
 
To facilitate comprehensive critical analysis, in addition to extracting data to describe 
the characteristics of the review, such as the number of studies included, year of 
publication and the total number of participants, data about the population, 
intervention, comparison and outcomes were extracted. These data were extracted 
with a standardised tool by two reviewers (AC & MH-B), and a third reviewer (RC) 
checked the data when uncertainties were encountered.  
Quality appraisal 
Included reviews were appraised by two independent reviewers for their quality and 
risk of bias using the AMSTAR tool (AC & MH-B). This is a measurement tool, with 
good content validity, for the assessment of multiple systematic reviews.7 The 11 
items of the AMSTAR were developed by building on empirical data collected with 
previously developed tools and with expert opinion. As such, the AMSTAR provided 
a valid, standardised method to assess the quality of methods used to search the 
literature and combine results as well as the comprehensiveness that results of the 
reviews were reported.7 Importantly, the AMSTAR criteria also provided a 
standardised method to determine the extent to which the scientific quality of the 
studies was assessed in the systematic reviews. This specific criterion was stated by 
the Cochrane Collaboration to be an important element to include in the preparation 
of a Cochrane overview of reviews.2 Our definition for ‘high-quality’ was a review that 
addressed at least 8 of the 11 AMSTAR criteria. We deemed that setting a cut-off for 
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the total score to indicate quality would be appropriate, as psychometric testing of 
the AMSTAR tool revealed that, as each component score measures a different 
domain of quality, the summary score is meaningful.7 
Data synthesis 
As many of the identified systematic reviews included the same studies, it was not 
appropriate to pool results from the individual meta-analyses.8 Thus, the data 
extracted from the systematic reviews are presented in tables and summary findings 
are presented in a narrative synthesis. 
RESULTS 
 
Overall, 65 publications from 3333 citations were identified as being potentially 
relevant. Seventeen fulfilled the inclusion and exclusion criteria in Figure 1. 
Systematic review characteristics 
The average number of studies included in the reviews was 19.5 (SD=14; range=5–
56) (Table 1). Eight reviews (47%) included only randomized controlled trials. A 
further eight reviews (47%) included a range of experimental, quasi-experimental 
and cohort designs, while one review also included findings from qualitative studies. 
Systematic review quality 
The quality of the reviews varied considerably, with AMSTAR scores ranging from 2-
11 (scale 0-11; mean 5.88; SD=2.75). Only the two reviews performed according to 
the Cochrane Collaboration method fulfilled all of the AMSTAR criteria.9, 10 Of note, 
eight reviews (47%) did not assess the scientific quality of the included studies and 
only three (43%) of the systematic reviews that performed meta-analyses accounted 
for publication bias.  
Methods used to synthesise results 
Page 8 of 21  
A minority of the systematic reviews (n=7; 41%) pooled results from individual 
studies for meta-analysis.9-15 Heterogeneity of interventions was managed by the 
authors of one of the Cochrane reviews by pooling results of interventions that are 
similar, namely telemonitoring and structured telephone support, separately.10 In 
contrast, the meta-analyses undertaken by Klersy et al.11, 12 considered all remote 
monitoring interventions together, including even invasive monitoring strategies, and 
used random-effects models to account for significant statistical heterogeneity.11, 12  
Most reviews that did not use meta-analysis used a narrative approach to synthesise 
the findings (n=8; 47%). The remainder (n=2; 12%) interpreted results based on the 
level of evidence produced according to the type of study design that was utilized 
(e.g. RCT=Level II evidence).16, 17  
Populations 
Table 2 summarizes the characteristics of the populations included in the reviews. 
Either the mean (including SD) or range of ages of participants was reported in all of 
the systematic reviews. The oldest reported mean age in a study was 82 years18 and 
the youngest was 44.5 years.10 Similarly, New York Heart Association (NYHA) Class 
of participants was reported in most reviews. The majority of reviews reported that 
participants were NYHA Class II-IV. 
In contrast, other population characteristics of the studies included in the systematic 
reviews were not reported consistently. For example, sex distribution was 
summarized in only five reviews,10-12, 18, 19 left ventricular ejection fraction (LVEF) 
reported in four, patients’ medications reported in only two reviews 13, 19 and a 
summary of comorbidities in only one systematic review.13 
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A single review reported sub-group populations within individual studies. Inglis et al10 
highlighted that studies included in their systematic review provided evidence of the 
effectiveness of remote monitoring in Hispanic and in older people with heart failure. 
Interventions and Technology 
Eight reviews (47%) considered all non-invasive remote monitoring strategies, 
including structured telephone support and automated telemonitoring.9, 15, 17, 18, 20, 21 
Five reviews (29%) focused specifically on telemonitoring, which involved automated 
physiologic and/or symptom monitoring.13, 16, 22-24 Four reviews (24%) included 
studies investigating both non-invasive and invasive remote monitoring 
technologies.11, 12, 25, 26 One review focused specifically on remote monitoring 
performed by nurses.15 None of the systematic reviews specifically focused on 
invasive remote monitoring.  
Outcomes 
Outcomes that were reported in the systematic reviews are summarized in Table 3. 
Death and hospitalizations were most often reported. Four reviews focused on only 
one specific outcome, including cost24, 27, patient satisfaction23 and self-care.21 It was 
also common for the reviews to report on healthcare costs, compliance with 
monitoring and patient satisfaction with, or acceptance of, the intervention.  
Mortality 
Five meta-analyses identified statistically significant improvements in all-cause 
mortality for remote monitoring compared with usual care9, 10, 12-14 Figure 2. Relative 
risk ranged from 0.53 (95% CI=0.29-0.96)12 to 0.88 (95% CI=0.76-1.01).10 The 
greatest benefit was seen in a meta-analysis of cohort studies, which included both 
non-invasive and invasive remote monitoring.12 Two meta-analyses suggested that 
the reduction in mortality with telemonitoring was more pronounced compared with 
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structured telephone support.10, 12 In the systematic reviews that did not incorporate 
meta-analysis, the authors concluded either that remote monitoring was beneficial or 
promising because the studies included in these reviews showed reductions in 
mortality. 
Hospitalizations 
There were more modest relative risk reductions from remote monitoring for all 
cause compared with CHF-related hospitalizations in the meta-analyses of RCTs 
Figure 3 and Figure 4. For example, the greatest relative risk reduction of 0.72 (95% 
CI=0.64-0.81) was for CHF-related hospitalization12 compared with 0.92 (95% 
CI=0.85-0.99) all-cause hospitalization.10  
Cost 
Two of the systematic reviews specifically examined the cost-effectiveness of remote 
monitoring for heart failure.11, 24 In the meta-analysis reported by Klersy et al,11 
remote monitoring was found to reduce costs compared with usual care with a gain 
in quality-adjusted life years (QALY) of 0.06, indicating superiority of this treatment 
over usual care in terms of effectiveness, cost and therefore cost-effectiveness. 
Another systematic review reported cost reductions associated with remote 
monitoring in the order of 1.6%-68.3%.24 The cost reductions were reported to result 
from reduced hospitalizations and patient travel costs. 
Self-care 
One systematic review focused specifically on the impact of remote monitoring on 
self-care.21 Most (n=8) studies included in this systematic review reported that 
remote monitoring improved (p<0.05) self-care behaviours such as frequency of 
obtaining daily weights, medication management, exercise adherence and fluid and 
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salt restriction.28, 29 However, the review identified five studies that showed there was 
no benefit to self-care from remote monitoring of heart failure.30, 31  
Quality of Life 
No meta-analyses of the impact of remote monitoring for heart failure on quality of 
life measures were identified. However, four systematic reviews reported that 
individual studies have identified significant (p<0.05) improvements in self-reported 
quality of life in heart failure patients randomized to a remote monitoring 
intervention.9, 10, 14, 26 
Compliance 
Compliance with the intervention was reported in five reviews Table 4. Compliance 
was generally reported to be high, ranging from 75-98.5%.10, 13, 17, 22, 25 
DISCUSSION 
Our meta-review is the first to appraise and synthesise published systematic reviews 
that have assessed the effectiveness of remote monitoring in heart failure. Results 
revealed the importance of conducting an appraisal of the current systematic reviews 
on this topic. By utilising the AMSTAR tool to appraise the quality of the systematic 
reviews, we were able to identify that eight published systematic reviews on remote 
monitoring in heart failure did not assess the scientific quality of the included studies. 
Two further reviews were judged to be of poor methodological quality, as the total 
AMSTAR score was below 8.  
Several reviews did, however, conform to the majority of the AMSTAR criteria. As 
such, this review has identified the systematic reviews on this topic that are of high 
quality and which, consequently, should be trusted to inform policy and practice 
decision making. These high quality reviews concluded that remote monitoring for 
heart failure improves mortality and quality of life as well as reduces hospitalizations 
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and, as a consequence, healthcare costs. Importantly, the reviews suggest that 
remote monitoring technologies are accepted as useful by patients. Perhaps as a 
result, compliance is also reported to be high. Based on these positive findings, 
further efforts should now be directed towards optimising remote monitoring in heart 
failure in preparation for more widespread implementation. In this regard, our review 
does provide some insights and recommendations for consideration in future 
research.  
For example, a high degree of heterogeneity was reported in many of the meta-
analyses included in this review. In the most recent Cochrane meta-analysis, 
heterogeneity of interventions was managed by stratifying trials according to the type 
of technology used, namely telemonitoring or structured telephone support, with the 
former strategy appearing superior.10 An alternative method to overcome the 
problem of heterogeneity regarding remote monitoring interventions in future 
systematic reviews could be to use the classification scheme for remote 
management of heart failure recently proposed by Anker, Koehler and Abraham.32 
Their classification scheme could potentially facilitate more consistent interpretation 
of data from clinical trials and systematic reviews focused on remote monitoring for 
heart failure because it incorporates both non-invasive and invasive remote 
monitoring technologies. This is an important consideration because the limitations 
of subjective sign and symptom monitoring as well as weight-based monitoring of 
fluid status indicate that invasive monitoring may be more sensitive and specific for 
the early detection of clinical deterioration.33 We found that no systematic review has 
yet focused specifically on invasive technologies for remote monitoring of heart 
failure.  
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While the mechanisms by which remote monitoring improves mortality and reduces 
the risk of hospitalizations for acute decompensated heart failure remains uncertain, 
the results of our meta-review provide some further insight. As might be expected, 
remote monitoring is more effective in reducing CHF-related hospitalizations than all-
cause hospitalizations. Although it has been proposed that better self-care improves 
early detection of and intervention for clinical deterioration improves morbidity and 
mortality, this review could not find substantial support for this hypothesis.21 Further 
research is required to elucidate why patients with heart failure generally experience 
better clinical outcomes when remote monitoring technologies are used.  
Anker, Koehler and Abraham noted in their recent discussion paper that a problem 
with meta-analyses of remote monitoring in heart failure is that the trials which are 
included enroll patients who “vary in clinical status, stability and degree of previous 
treatment (p. 736)”.32 In concordance with their statement, we found that no specific 
determination as to the effect of remote monitoring in a particular subset of the heart 
failure population could be derived from the systematic reviews either. Standardized 
reporting of population characteristics in future research would aid determination of 
which particular subsets of the population with heart failure benefit from remote 
monitoring interventions. 
The results of the higher quality meta-analyses included in this meta-review are in 
contrast with two randomised controlled trials of remote monitoring for heart failure 
that have only recently been published, TIM-HF and Tele-HF; neither of which 
demonstrated an improvement in outcomes compared with usual care.19, 27 Data 
from these trials will need to be incorporated into an updated meta-analysis. Two 
conclusions can be drawn from their results in isolation however. Tele-HF used a 
voice-interactive system that appears to have been disliked by many patients; 14% 
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of patients randomized to telemonitoring did not use the technology and only 55% 
used the technology at least 3 times per week. In contrast, compliance was reported 
to range from 75% to 98.5% in higher quality meta-analyses.10, 25 No per-protocol 
analysis has been reported from the Tele-HF study to investigate whether the poor 
compliance in this RCT affected the results. Although Tele-HF was of high quality in 
terms of trial design and reporting, one trial using a specific technology that was 
rejected by many patients does not negate the positive findings of earlier meta-
analyses. As such, the first conclusion from the negative findings of these two trials 
is that further research is required in this area to determine the most optimal type of 
telemonitoring intervention.   
A further conclusion can be drawn from results of TIM-HF. The patients enrolled in 
this trial required little variance in treatment, likely due to the fact they were medically 
stable at the time of enrollment.27 Sub-group analyses demonstrated that the 
participants who were hospitalized due to exacerbation of heart failure prior to 
randomization derived the most benefit from the intervention.34 Thus, this trial 
provides evidence that it is not the simple act of remote monitoring that mediates 
improved clinical outcomes for patients with heart failure yet a more complex 
interaction involving the impact of responses to symptoms actioned by the patient 
and the health care provider. The complexity of this interaction is not yet completely 
understood and requires further investigation. Further research is therefore required 
to determine the time-point in the course of heart failure at which remote monitoring 
should be applied and an optimal duration for its usage. 
To the authors’ knowledge, only one other telemedicine-focused meta-review has 
used the AMSTAR instrument to appraise the quality of systematic reviews.35 
However, we considered that this tool would be appropriate, as it has good content 
Page 15 of 21  
validity and it has been used previously to appraise the quality of meta-analyses in 
heart failure disease management programs.7,36  
It should be noted that only English language reviews were included. However, we 
considered this to be acceptable because sensitivity testing regarding information 
published in languages other than English has shown that English language reviews 
represent a robust view of the available evidence base in health areas.37  
In conclusion, our meta-review has provided important information for policy and 
practice decision-makers regarding the application of remote monitoring 
interventions for the management of patients with heart failure. By using the 
AMSTAR tool for quality appraisal, we identified the systematic reviews focused on 
remote monitoring for heart failure that are of high quality and which should be 
trusted to inform decision-making. Results of these high quality reviews suggest that 
policy and practice-decision makers can expect the following benefits from remote 
monitoring of patients with heart failure: 1) reductions in all-cause and heart failure-
related hospitalizations; 2) reductions in all-cause mortality;3) reductions in 
healthcare costs; and 4) improved quality of life. However, further research is 
required to optimize these interventions in preparation for more widespread 
implementation. In this regard, the specific subsets of the heart failure population 
that derives the most benefit from intensified monitoring, the particular type or 
combination of technology that provides the best platform for the collection, 
transmission and interpretation of data and the optimal duration that patients should 
be monitored, needs to be identified.  
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Box 1 Inclusion and exclusion criteria 
 
Systematic Review inclusion criteria 
• Study type: Systematic review of original research (as per the 
PRISMA statement. A systematic review was defined as a review with 
a clearly formulated question that used systematic and explicit methods 
to identify, select and critically appraise relevant research and to collect 
and analyse data from the studies that were included in the review.6, 35 
As such, the review had to describe a detailed search of the literature 
for relevant studies and synthesis of results) 
• Publication: Full peer-reviewed publication 
• Population: Adult patients with a definitive diagnosis of heart failure 
and recently discharged from an acute care setting to home (excluding 
nursing  homes or convalescent homes) or recruited while managed in 
the community setting  
• Intervention: Remote monitoring of patients with heart failure (daily, 
weekly, and monthly) 
Initiated by a healthcare professional (medical, nursing, social work, 
pharmacist). 
Delivered as the only heart failure disease management intervention, 
without home-visits or intensified clinic follow-up 
Targeted towards the patient, and not caregivers 
Did not include any visits at home by a specialized CHF healthcare 
professional or study personnel for the purpose of education or clinical 
assessment other than an initial visit to set-up equipment 
• Comparison: Consisted of standard post-discharge care without 
intensified attendance at cardiology clinics or clinic-based CHF disease 
management programme or home-visits 
• Outcomes: All-cause mortality, CHF-related or all-cause 
hospitalizations, length of stay, cost of the intervention or cost 
reductions, quality of life, acceptability, and adherence 
 
Systematic Review exclusion criteria 
• Remote monitoring of conditions other than heart failure 
• Reviews could not include studies that involved home-visits by 
specialized CHF health professionals or study personnel for the 
purpose of education or clinical assessment or include intensified clinic 
follow-up 
  
Table 1 Characteristics of included reviews 
 
Systematic reviews with meta-analysis 
Author 
(Year) 
Journal  Number of studies Participants Interventions Authors’ conclusions AMSTAR 
Score 
Clark et al. 
(2007)9 
British 
Medical 
Journal  
14 RCTs 4264 
• Telemonitoring 
• Structured telephone 
support 
 
• Reduced CHF-related 
admissions and all-cause 
mortality.  
• Results were mixed for QoL 
and costs.  
11 
Inglis et al. 
(2010)10 
Cochrane 
Database of 
Systematic 
Reviews 
 
25 RCTs in total 
16 STS 
11 Telemonitoring 
5613 
Structured 
Telephone 
Support 
2710 
Telemonitorin
g 
• Telemonitoring 
• Structured telephone 
support 
 
• STS and telemonitoring 
effective in reducing risk of 
all-cause mortality and CHF-
related hospitalisations  
• Improves QoL, reduce costs 
and evidence-based 
prescribing. 
11 
Polisena et 
al. (2010)14 
Journal of 
Telemedicine 
and Telecare  
21 studies included 
8 RCTs telemonitoring 
vs usual care 
4 telemonitoring, STS, 
usual care 
9 cohort 
3082 
• Telemonitoring 
• Structured telephone 
support 
• Reduced mortality (6 
studies) 
• Reduced hospitalisations (4 
studies) 
9 
Lee et al. 
(2010)15 
Joanna 
Briggs 
Institute 
Library of 
Systematic 
Reviews 
(n/a) 
10 RCTs  2148 
• Only included 
telephone-based post 
discharge nursing care 
 
• 4 studies included in meta-
analysis at 3 and 6 months 
follow-up 
• 5 studies included in meta-
analysis at 12 months 
8 
follow-up 
• Intervention decreases 
readmissions 
Klersy et al. 
(2011)11 
European 
Journal of 
Heart Failure  
21 RCTs 5715 
• Telemonitoring 
(includes data from 
invasive technologies) 
• Structured telephone 
support 
• Remote-monitoring reduces 
costs compared with usual 
care 
8 
Klersy et al. 
(2009)12 
Journal of the 
American 
College of 
Cardiology  
20 RCTs 
12 cohort studies 
6258 in 
RCTs 
2354 in 
cohort 
studies 
• Telemonitoring 
(includes data from 
invasive technologies) 
• Structured telephone 
support 
 
• Significant protective clinical 
effect 
• Decrease in events greater 
in cohort studies than RCTs 
8 
Clarke et al 
(2011)13 
Journal of 
Telemedicine 
and Telecare  
 
13 RCTs of 
telemonitoring 
3480 
• Telemonitoring 
 
• Reduced mortality and CHF-
related hospitalisation 
3 
Systematic reviews without meta-analysis 
Author (Year) Journal 
(Impact 
Factor in 
year 
published) 
Number of studies Participants Intervention Authors’ conclusions AMSTAR 
Score 
Chaudhry et 
al. (2007)20 
Journal of 
Cardiac 
Failure  
9 RCTs 
5-telemon 
1-automated 
1-physiologic 
3582 
• Telemonitoring 
• Structured telephone 
• Synthesis of results 
suggested the interventions 
are promising but evidence 
base was limited. 
8 
support 
 
Cherofsky et 
al. (2011)18 
Joanna 
Briggs 
Institute 
Library of 
Systematic 
Reviews  
3 RCTs and 2 quasi-
experimental 
612 
• Telemonitoring 
• Structured telephone 
support 
 
• Results equivocal 
• One RCT showed 
statistically significant 
improvement in ED 
admissions and re-
hospitalisation rates 
7 
Dang et al. 
(2009)16 
Telemedicin
e and e-
Health  
5 RCTs of automated 
remote monitoring of 
signs and symptoms 
or physiologic data 
(not patient-reported) 
1126 
• Focused on automated 
monitoring 
 
• Telemonitoring a promising 
strategy.  
• More research required. 
5 
Louis et al. 
(2003)25 
European 
Journal of 
Heart 
Failure  
6 cohort 
6 RCT 
12 quasi-experiment 
designs 
2629 
• Includes invasive 
monitoring and video 
consultations 
• Telemonitoring 
• Structured telephone 
support 
• Intervention promising yet 
adequately powered studies 
required. 
5 
Giamouzis et 
al. (2012)22 
Cardiology 
Research 
and Practice  
12 RCTs 3877 
• Telemonitoring • Studies reviewed are “in 
favour” of telemonitoring.  
5 
Kraai et al. 
(2011)23 
Journal of 
Cardiac 
Failure  
14 studies 
4 RCT 
7 pilot 
1 Observational study 
2005 
• Non-invasive remote 
monitoring with 
external equipment to 
• In general, patients seemed 
to be satisfied or very 
satisfied with the use of 
5 
1 Evaluation study 
1 Efficacy study 
measure physiological 
data 
telemedicine 
• Measurement of patient 
satisfaction with 
telemonitoring has used 
poorly constructed 
questionnaires 
Maric et al. 
(2009)26 
European 
Journal of 
Heart 
Failure  
56 studies 
16 device-based 
12 telephone 
touchpad 
3 video consults 
5 website-based 
21 combination 
(device and nurse-
telephone contact) 
4417 (7 
studies did 
not specify 
number of 
participants) 
• Automated 
physiologic/symptom 
monitoring 
• Telephone touch-pad 
• Video consultations 
• Website-based 
modalities 
• Combination of 
telemonitoring 
modalities (telephone 
support with 
automated monitoring) 
• Most studies showed 
improvement in outcomes 
• Some studies were small 
4 
Martinez et al 
(2006)17 
Journal of 
Telemedicin
e and 
Telecare  
42 studies 
13 RCTs 
10 Quasi-
experimental designs 
19 cohort 
2303 (5 
studies did 
not specify 
number of 
participants) 
• Telemonitoring • Technically feasible 
• Easy to use and accepted 
by patients 
• Economically viable 
• Improves outcomes 
4 
Radhakrishna
n & Jacelon 
(2012)21  
Journal of 
Cardiovascu
lar Nursing 
(1.431) 
14 studies 
8 RCT 
2 pre-post test 
1 quasi- experimental 
designs 
1 controlled pilot 
1 qualitative 
1 mixed-method 
1452 
• Telemonitoring 
• Video-consultation 
• Structured telephone 
support 
• Focused on impact of 
telehealth on self-care 
• 5 studies improved self-care 
and 5 did not 
3 
Seto (2008)24 Telemedicin
e and e-
Health (n/a) 
10 studies 
7 RCTs 
1 Quasi-experimental 
designs 
1 Cohort 
1 Survey 
1394 
• Physiologic 
measurements only 
• All studies found cost 
reductions mostly related to 
decreased hospitalisation 
expenditures 
• 3.5% lower cost in travelling 
for patients 
2 
 
Table 2 Population characteristics 
Systematic reviews with meta-analysis 
Author (Year) Age Medication 
summary 
NYHA LVEF Sub-populations 
Clarke et al. 
(2011)13 
Mean 55-85 
years 
Included in 6 of 
13 studies 
Not reported All studies included patients 
<40% 
Co-morbidities summarized 
in 6 of 13 studies 
Inglis et al. 
(2011)10 
44.5-78 Not summarised Not summarised Not summarised Hispanic and elderly 
included. 
Mean 64% male (range 35-
99%) 
Klersy et al. 
(2011)11 
Median 70.7 
Range: 45-78 
Not summarised Reported in 18 
RCTs 
48.1% Class III-IV 
Not summarised 64% male 
Lee et al. 
(2010)15 
Most studies 
>60 
Not summarised Not summarised Not summarised Not summarised 
Polisena et al. 
(2010)14 
All studies had 
mean age over 
55 
Not summarised Most III-IV Not summarised Not summarised 
Klersy et al. 
(2009)12 
RCT’s Median 
70 Range 54-
78 
Cohort Median 
66 Range 59-
81 
Not summarised RCTs III-IV = 
54% 
Cohort III-IV=83% 
RCTs Median 35% Range 
22-43 
Cohort Median 40 Range 
35-44 
RCTs 64% male 
Cohort 60% male 
Clark et al. 
(2007)9 
57-75 Not summarised II-IV Not summarised Not summarised 
Systematic reviews without meta-analysis 
Author (Year) Age Medication 
summary 
NYHA LVEF Sub-populations 
Chaudhry et al. 
(2007)20 
Mean 65-72 ACE (range 
54-93%) and 
beta-locker 
(range 17-
Majority class III-
IV 
Not summarised Men range 46%-71% 
62%) at 
discharge  
Cherofsky et al. 
(2011)18 
22-98 years Not 
summarised 
Not summarised Not summarised Men range 46%-71% 
Dang et al. 
(2009)16 
Means range 
from 57-63 
Not 
summarised 
Range II-IV Not summarised Not summarised 
Giamouzis et al. 
(2012)22 
57-58 Not 
summarised 
II-IV 23-35% Not summarised 
Kraai et al. 
(2011)23 
Means ranged 
50-78 
Not 
summarised 
Not summarised Not summarised Not summarised 
Louis et al. 
(2003)25 
Means range 
53-82 
Not 
summarised 
Most II-IV, one 
study I-III 
Mean range 20-42% Not summarised 
Maric et al. 
(2009)26 
Not summarised Not 
summarised 
Ranged 1-IV Not summarised Not summarised 
Martinez et al 
(2006)17 
48-82 Not 
summarised 
I-IV Not summarised Not summarised 
Radhakrishnan  
& Jacelon 
(2012)21  
Not summarised Not 
summarised 
Not summarised Not summarised Not summarised 
Seto (2008)24 Means ranged 
from 58-74 
Not 
summarised 
Not summarised Not summarised Males ranged from 33%-97%  
Table 3 Outcomes reported on in the systematic reviews 
Study Outcomes 
Mortality Hospital-
isation 
Cost ED 
visit 
QoL Compliance Acceptability LoS Clinic 
visits 
NYHA 
Class 
6 min 
walk 
test 
Pharmaco
-therapy 
Self 
care 
Satis-
faction 
Feas-
ibility 
Impact 
Systematic reviews with meta-analysis 
Clark et al. 
(2007)9 
x x x  x x x          
Inglis et al. 
(2010)10 
x x    x x   x x x x    
Polisena et al. 
(2010)14 
x x  x x   x x     x   
Lee et al. 
(2010)15 
 x               
Klersy et al. 
(2011)11 
  x              
Klersy et al. 
(2009)12 
x x               
Clarke et al 
(2011)13 
x x  x    x         
Systematic reviews without meta-analysis 
Chaudhry et al. 
(2007)20 
x x x              
Cherofsky et al. 
(2011)18 
 x  x             
Dang et al. 
(2009)16 
x x x x    x x        
Louis et al. 
(2003)25 
x x x   x x x         
Giamouzis et al. 
(2012)22 
x x x              
Kraai et al. 
(2011)23 
             x   
Maric et al. 
(2009)26 
 x  x x   x         
Martinez et al 
(2006)17 
              x x 
Radhakrishnan 
& Jacelon 
(2012)21  
            x    
Seto (2008)24   x              
Legend: ED=Emergency department; QoL=Quality of life; LoS=Length of stay in hospital; NYHA=New York Heart Association.  
Table 4 Compliance with the intervention 
  
Review Reported 
(Yes/No) 
Results 
Chaudhry et al. (2007)20 No  
Cherofsky et al. (2011)18 No  
Clark et al. (2007)9 No  
Clarke et al. (2011)13 Yes Six studies showed high levels of 
compliance 
Dang et al. (2009)16 No  
Giamouzis et al. (2012)22 Yes 75-98.5% 
Inglis et al. (2011)10 Yes 80-97% 
Klersy et al. (2009)12 No  
Klersy et al. (2011)11 No  
Kraai et al. (2011)23 No  
Lee et al. (2010)15 No  
Louis et al. (2003)25 Yes “good acceptability ranging from 
80-90%” p584 
Maric et al. (2009)26 No  
Martinez et al (2006)17 Yes One randomised controlled trial 
showed that 88% of the patients 
rated the equipment as ‘very 
easy to use’ p236 
Polisena et al. (2010)14 No  
Radhakrishnan& Jacelon 
(2012)21 
No  
Seto (2008)24 No  
Records identified through 
database searching
n = 3173
Additional records 
identified from forward 
citation search
n = 166 
Records after duplicates 
removed
n = 3167
Records screened
n = 3333
Records excluded
n = 3268
Full-text articles 
assessed for eligibility
n = 65
Reviews included 
in synthesis
n = 17
Full-text articles excluded, with reasons
Systematic search strategy not used n = 41
Not heart failure specific n = 1
Remote rehabilitation not monitoring n = 1
Included reviews n = 2
Technology not focused on remote monitoring n = 3
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Figure 2. All-cause mortality results from meta-analyses
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Figure 4. Heart failure-related hospitalizations results from meta-analyses
0.79 (0.67-0.94)
Clark et al.9 0.79 (0.69-0.89)
Klersy et al.12 RCTs: 0.72 (0.64-0.81)
Clarke et al.13 0.73 (0.62-0.87)
 Appendix – Search terms 
S34  33 AND 30   
S33  31 OR 32   
S32  TI meta-analysis OR AB meta-analysis   
S31  PT systematic review   
S30  28 and 29   
S29  
telecommunications/ or interactive voice response systems/ or telecommuting/ 
or teleconferencing/ or telefacsimile/ or telehealth/ or telemedicine/ or remote 
consultation/ or telepathology/ or teleradiology/ or telenursing/ or telepsychiatry/ 
or telephone/ or wireless communications/   
S28  27 and 4   
S27  or/5-26   
S26  
patient discharge/ or discharge planning/ or early patient discharge/ or patient 
discharge education/ or transfer, discharge/   
S25  (discharge adj plan*)   
S24  multidisciplin*   
S23  
nurses/ or advanced practice nurses/ or clinical nurse specialists/ or nurse 
practitioners/ or case managers/   
S22  nurs*   
S21  
community health nursing/ or home nursing, professional/ or rehabilitation 
nursing/ or rural health nursing/   
S20  
rehabilitation/ or rehabilitation, cardiac/ or conditioning, cardiopulmonary/ or 
rehabilitation, community-based/   
S19  rehabilitat*   
 S18  homecare   
S17  (disease adj management)   
S16  secondary adj prevent*   
S15  home adj intervention*   
S14  
patient care/ or after care/ or cardiovascular care/ or home nursing/ or nursing 
care/ or self care/ or self administration/ or self medication/   
S13  home care.mp   
S12  
home health care/ or home apnea monitoring/ or home intravenous therapy/ or 
home nursing, professional/   
S11  (home adj care)   
S10  
health maintenance organizations/ or medical practice/ or nursing practice/ or 
advanced nursing practice/ or nursing practice, evidence-based/ or nursing 
practice, research-based/ or nursing practice, theory-based/ or “scope of nursing 
practice”/ or occupational therapy practice/ or prescribing patterns/ or 
prescriptive authority/ or professional practice, evidence-based/ or medical 
practice, evidence-based/ or exp nursing practice, evidence-based/ or 
occupational therapy practice, evidence-based/or physical therapy practice, 
evidence-based/ or exp professional practice, research-based/ or exp 
professional practice, theory-based/  
S9  
managed care programs/ or health maintenance organizations/ or independent 
practice associations/ or preferred provider organizations/ or provider-sponsored 
organizations/   
S8  (manag* adj care)   
S7  patient care/ or casemanagement/ or “continuity of patient care”/ or discharge 
 planning/ or disease management/ or multidisciplinary care team/ or nursing 
care/ or nursing care delivery systems/ or differentiated nursing practice/ or 
functional nursing/ or modular nursing/ or primary nursing/ or progressive patient 
care/ or team nursing/ or total patient care nursing/ or nursing care studies/ or 
nursing intensity/ or nursing process/ or nursing assessment/ or nursing care 
plans/ or nursing diagnosis/ or nursing interventions/ or nursing outcomes/ or 
nursing protocols/ or nursing care plans, computerized/ or nursing skills/ or 
patient care conferences/ or clinical conferences/ or patient-family conferences/ 
or primary health care/ or “quality of health care”/ or accountability/ or guideline 
adherence/ or “outcomes (health care)”/ or medical futility/ or outcome 
assessment/ or “outcomes of prematurity”/ or treatment outcomes/ or fatal 
outcome/ or treatment failure/ or practice guidelines/  
S6  patient adj care   
S5  home adj care   
S4  1 or 2 or 3   
S3  (cardiac adj failure).tw   
S2  (heart adj failure).tw.   
S1  
cardiac output, decreased/ or heart failure, congestive/ or dyspnea, paroxysmal/ 
or ventricular dysfunction/ or ventricular dysfunction, left/ or ventricular 
dysfunction, right/  
 
